Skip to content

Smartphone intervention for people from Bosnia and Herzegovina with traumatic experiences and symptoms of depression: a randomized controlled trial

Smartphone intervention for people from Bosnia and Herzegovina with traumatic experiences and symptoms of depression: a randomized controlled trial - SerApp

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00025696
Enrollment
200
Registered
2021-07-06
Start date
2020-04-21
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32 F43

Interventions

Group 1: Interventional = smartphone intervention to treat symptoms of depression and psychological trauma. Group 2: Wait-list control group = no additional intervention within the framework of the st

Sponsors

University Medical Center Hamburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: • consent to participate in study (informed consent) • sufficient understanding of the Serbian language • willingness to participate in two assessment • Sufficient understanding of Serbian/Croatian/Bosnian language • Willingness to participate in two online surveys • Willingness to participate in a four-week smartphone intervention • Willingness to provide an (anonymous) email address • Symptoms of depression

Exclusion criteria

Exclusion criteria: • lifetime schizophrenia (F.20) or bipolar disorder • severe neuropsychological disease • acute suicidal tendencies

Design outcomes

Primary

MeasureTime frame
Patient Health Questionnaire – 9 (PHQ-9) is a diagnostic instrument of 9-item setting to screen for the persistence and severity of depression. It is designed for use with adults in assessing and monitoring each of the 9 DSM-4 criteria for major depressive disorder (baseline, post after 4 weeks).

Secondary

MeasureTime frame
The Life Events Checklist for DSM-5 (LEC-5) is a measure developed at the National Center for Posttraumatic Stress Disorder (PTSD) to screen for traumatic events in respondent’s lifetime and facilitate the diagnosis of PTSD (baseline, post). The Posttraumatic Stress Disorder Checklist (PCL-5) is a self-report measure of PTSD symptoms also developed at the National Center for Posttraumatic Stress Disorder (PTSD). Purposes of the instrument are: monitoring symptoms change during and after treatment, screening individuals for PTSD, making a provisional PTSD diagnosis (baseline, post). The Posttraumatic Cognitions Inventory (PTCI; Foa et al., 1999) is a self-report measure of thoughts and beliefs typically associated with trauma. The three subscales of the PTCI include: Negative Cognitions about the Self (negative beliefs regarding him/herself), Negative Cognitions about the World (negative beliefs about others and the safety of the world), and self-blame (blame attributed to the self-regarding the traumatic event) (baseline, post). The Emotion Regulation Questionnaire (ERQ; Gross, J.J. & John, O.P., 2003) is a scale developed to measure respondent’s tendency to regulate their emotions examined in two forms: 1. Cognitive Reappraisal and 2. Expressive Suppression (baseline, post). The Quality of life assessment (WHOQOL-BREF) was developed detailed by the WHOQL group with fifteen international field centres. This assessment is applicable cross-culturally. The 26 items are grouped into 4 domains: 1. Physical health, 2. Psychological, 3. Social relationships, 4. Environment (baseline, post). Rosenberg Self-Esteem Scale (RSE) is a self-report inventory for evaluating self-esteem assessing positive and negative feelings about the self (baseline, post). Inventory for the balanced assessment of negative effects of psychotherapy is a self-report instrument accessing negative effects of psychotherapy (post). Subjective Evaluation of the Program: The subjective evaluation of

Countries

Germany

Contacts

Public ContactSteffen Moritz

University Medical Center Hamburg

moritz@uke.de040741056565

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026